Novo Nordisk Says Wegovy Cuts Heart Risk by 57% Compared With Eli Lilly’s Obesity Drug

D

Dominic Chopping

Guest
The study used evidence gathered from patient experiences rather than a controlled trial, Novo said.

Continue reading...
 


Join 𝕋𝕄𝕋 on Telegram
Channel PREVIEW:
Back
Top